共 9 条
- [1] 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cellsCHEMICO-BIOLOGICAL INTERACTIONS, 2018, 284 : 24 - 31Han, Mengting论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaShen, Jiwei论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaWang, Lijing论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaWang, Yu论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaZhai, Xin论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaLi, Yao论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaLiu, Meiqiao论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaLi, Zengqiang论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaZuo, Daiying论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R ChinaWu, Yingliang论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China
- [2] 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl) amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cellsTOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 450Chang, Xing论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaWang, Junfang论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaBian, Jiang论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaLiu, Zi论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaGuo, Ming论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Key Lab Struct Based Drug Design & Discovery, Minist Educ, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaLi, Zengqiang论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaWu, Yingliang论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaZhai, Xin论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Key Lab Struct Based Drug Design & Discovery, Minist Educ, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaZuo, Daiying论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China
- [3] Discovery of N-{2-Methoxy-4-14-(4-methylpiperazin-1-yl)piperidin-l-yl]phenyl}-N′-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine (ASP3026), a Potent and Selective Anaplastic Lymphoma Kinase (ALK) InhibitorCHEMICAL & PHARMACEUTICAL BULLETIN, 2018, 66 (03) : 251 - 262Iikubo, Kazuhiko论文数: 0 引用数: 0 h-index: 0机构: Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, JapanKondoh, Yutaka论文数: 0 引用数: 0 h-index: 0机构: Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan Omnica Co Ltd, Res & Dev Dept, Bunkyo Ku, TN Koishikawa Bldg 5F,1-15-17 Koishikawa, Tokyo 1120002, Japan Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, JapanShimada, Itsuro论文数: 0 引用数: 0 h-index: 0机构: Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, JapanMatsuya, Takahiro论文数: 0 引用数: 0 h-index: 0机构: Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, JapanMori, Kenichi论文数: 0 引用数: 0 h-index: 0机构: Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, JapanUeno, Yoko论文数: 0 引用数: 0 h-index: 0机构: Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, JapanOkada, Minoru论文数: 0 引用数: 0 h-index: 0机构: Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan Yonezawa Hamari Chem Ltd, Technol Dept, 2-4300-18 Hachimampara, Yonezawa, Yamagata 9921128, Japan Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan
- [4] 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cellsJOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (10) : 1370 - 1382Wang, Lijing论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaXu, Xiaobo论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaLiu, Tong论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaWang, Junfang论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaShen, Jiwei论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaGuo, Ming论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaWu, Yingliang论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaZhai, Xin论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R ChinaZuo, Daiying论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China
- [5] Synthesis, Structure-Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical TrialsJOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (14) : 5675 - 5690Marsilje, Thomas H.论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAPei, Wei论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAChen, Bei论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USALu, Wenshuo论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAUno, Tetsuo论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAJin, Yunho论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAJiang, Tao论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAKim, Sungjoon论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USALi, Nanxin论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAWarmuth, Markus论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USASarkisova, Yelena论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USASun, Frank论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USASteffy, Auzon论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAPferdekamper, AnneMarie C.论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USALi, Allen G.论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAJoseph, Sean B.论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAKim, Young论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USALiu, Bo论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USATuntland, Tove论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USACui, Xiaoming论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAGray, Nathanael S.论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USASteensma, Ruo论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAWan, Yongqin论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAJiang, Jiqing论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAChopiuk, Greg论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USALi, Jie论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAGordon, W. Perry论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USARichmond, Wendy论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAJohnson, Kevin论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAChang, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAGroessl, Todd论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAHe, You-Qun论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAPhimister, Andrew论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAAycinena, Alex论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USALee, Christian C.论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USABursulaya, Badry论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAKaranewsky, Donald S.论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USASeidel, H. Martin论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAHarris, Jennifer L.论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USAMichellys, Pierre-Yves论文数: 0 引用数: 0 h-index: 0机构: Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA
- [6] 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cells (vol 72, pg 1370, 2020)JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (05) : 718 - 718Wang, Lijing论文数: 0 引用数: 0 h-index: 0Xu, Xiaobo论文数: 0 引用数: 0 h-index: 0Liu, Tong论文数: 0 引用数: 0 h-index: 0Wang, Junfang论文数: 0 引用数: 0 h-index: 0Shen, Jiwei论文数: 0 引用数: 0 h-index: 0Guo, Ming论文数: 0 引用数: 0 h-index: 0Wu, Yingliang论文数: 0 引用数: 0 h-index: 0Zhai, Xin论文数: 0 引用数: 0 h-index: 0Zuo, Daiying论文数: 0 引用数: 0 h-index: 0
- [7] Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal TumorsJOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) : 8797 - 8810Kettle, Jason G.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandAnjum, Rana论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, 35 Gatehouse Pk, Waltham, MA 02451 USA AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandBarry, Evan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, 35 Gatehouse Pk, Waltham, MA 02451 USA H3 Biomed Inc, 3520,300 Technol Sq,Floor 5, Cambridge, MA 02139 USA AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandBhavsar, Deepa论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, 35 Gatehouse Pk, Waltham, MA 02451 USA AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandBrown, Crystal论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, 35 Gatehouse Pk, Waltham, MA 02451 USA AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandBoyd, Scott论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandCampbell, Andrew论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandGoldberg, Kristin论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandGrondine, Michael论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, 35 Gatehouse Pk, Waltham, MA 02451 USA AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandGuichard, Sylvie论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, 35 Gatehouse Pk, Waltham, MA 02451 USA Forma Therapeut Inc, 500 Arsenal St, Watertown, MA 02472 USA AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandHardy, Christopher J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandHunt, Tom论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandJones, Rhys D. O.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandLi, Xiuwei论文数: 0 引用数: 0 h-index: 0机构: Pharmaron Beijing Co Ltd, 6 Taihe Rd BDA, Beijing 100176, Peoples R China AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandMoleva, Olga论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandOgg, Derek论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England Peak Prot Ltd, 3G48 Mereside,Alderley Pk, Macclesfield SK10 4TG, Cheshire, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandOverman, Ross C.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandPacker, Martin J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandPearson, Stuart论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandSchimpl, Marianne论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandShao, Wenlin论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, 35 Gatehouse Pk, Waltham, MA 02451 USA AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandSmith, Aaron论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandSmith, James M.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandStead, Darren论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandStokes, Steve论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandTucker, Michael论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, EnglandYe, Yang论文数: 0 引用数: 0 h-index: 0机构: Pharmaron Beijing Co Ltd, 6 Taihe Rd BDA, Beijing 100176, Peoples R China AstraZeneca, IMED Biotech Unit, Oncol, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England
- [8] Synthesis, antimicrobial, insecticidal and anthelmintic activity studies of some new alkyl/aryl 6-(4-(4-(4-methyl-1H-1,2,3-triazol-1-yl)phenyl amino)phenyl)-N2,N4-bis(4-methoxyphenyl)-1,3,5-triazin-2,4-diamine carbamic acid ester derivativesINDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2012, 51 (07): : 1020 - 1026Gautam, Nidhi论文数: 0 引用数: 0 h-index: 0机构: Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Sagar 470003, India Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Sagar 470003, IndiaChourasia, O. P.论文数: 0 引用数: 0 h-index: 0机构: Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Sagar 470003, India Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Sagar 470003, India
- [9] Discovery of 5 Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat PathwayJOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 262 - 276Ioannidis, Stephanos论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USALamb, Michelle L.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAWang, Tao论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAAlmeida, Lynsie论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USABlock, Michael H.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USADavies, Audrey M.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAPeng, Bo论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USASu, Mei论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAZhang, Hai-Jun论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Chem, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAHoffmann, Ethan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Drug Metab & Pharmacokinet, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USARivard, Caroline论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Drug Metab & Pharmacokinet, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAGreen, Isabelle论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cells Prot & Struct Sci, Discovery Enabling Capabil & Sci, Macclesfield SK10 4TG, Cheshire, England AstraZeneca R&D, Dept Canc Chem, Boston, MA USAHoward, Tina论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cells Prot & Struct Sci, Discovery Enabling Capabil & Sci, Macclesfield SK10 4TG, Cheshire, England AstraZeneca R&D, Dept Canc Chem, Boston, MA USAPollard, Hannah论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cells Prot & Struct Sci, Discovery Enabling Capabil & Sci, Macclesfield SK10 4TG, Cheshire, England AstraZeneca R&D, Dept Canc Chem, Boston, MA USARead, Jon论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cells Prot & Struct Sci, Discovery Enabling Capabil & Sci, Macclesfield SK10 4TG, Cheshire, England AstraZeneca R&D, Dept Canc Chem, Boston, MA USAAlimzhanov, Marat论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Biosci, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USABebernitz, Geraldine论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Biosci, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USABell, Kirsten论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Biosci, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAYe, Minwei论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Biosci, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAHuszar, Dennis论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Biosci, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USAZinda, Michael论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Canc Biosci, Boston, MA USA AstraZeneca R&D, Dept Canc Chem, Boston, MA USA